235 related articles for article (PubMed ID: 24151434)
1. Risk factors for invasive pulmonary aspergillosis and hospital mortality in acute-on-chronic liver failure patients: a retrospective-cohort study.
Chen J; Yang Q; Huang J; Li L
Int J Med Sci; 2013; 10(12):1625-31. PubMed ID: 24151434
[TBL] [Abstract][Full Text] [Related]
2. Improving survival of acute-on-chronic liver failure patients complicated with invasive pulmonary aspergillosis.
Gao J; Zhang Q; Wu Y; Li Y; Qi T; Zhu C; Liu S; Yu R; He Q; Wen W; Zhou F; Chen Y; Chen J; Hou J
Sci Rep; 2018 Jan; 8(1):876. PubMed ID: 29343867
[TBL] [Abstract][Full Text] [Related]
3. Invasive pulmonary aspergillosis in patients with acute-on-chronic liver failure.
Wu Z; Ling Z; Shao F; Sheng J; Li L
J Int Med Res; 2012; 40(5):1958-65. PubMed ID: 23206479
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of voriconazole in the treatment of invasive pulmonary aspergillosis in patients with liver failure: study protocol for a randomized controlled clinical trial.
Yu X; Xu L; Zheng J; Lei Z; Pang Y; Li X; Zhu J; Liu J
Trials; 2023 Dec; 24(1):811. PubMed ID: 38105213
[TBL] [Abstract][Full Text] [Related]
5. Invasive Pulmonary Aspergillosis in Acute-on-Chronic Liver Failure Patients: Short-Term Outcomes and Antifungal Options.
Chen D; Qian Z; Su H; Meng Z; Lv J; Huang Y; Gao Y; Liu J; Zhao C; Gao H; Chen Y; Xia J; Peng L; Han T; Li H; Zheng X; Wang X; Lu X; Shi Y; Hu J; Chen J
Infect Dis Ther; 2021 Dec; 10(4):2525-2538. PubMed ID: 34468963
[TBL] [Abstract][Full Text] [Related]
6. Invasive pulmonary aspergillosis in patients with solid tumours: risk factors and predictors of clinical outcomes.
Dandachi D; Wilson Dib R; Fernández-Cruz A; Jiang Y; Chaftari AM; Hachem R; Raad I
Ann Med; 2018 Dec; 50(8):713-720. PubMed ID: 30230385
[TBL] [Abstract][Full Text] [Related]
7. Invasive pulmonary aspergillosis in critically ill patients with hematological malignancies.
Pardo E; Lemiale V; Mokart D; Stoclin A; Moreau AS; Kerhuel L; Calvet L; Valade S; De Jong A; Darmon M; Azoulay E
Intensive Care Med; 2019 Dec; 45(12):1732-1741. PubMed ID: 31599334
[TBL] [Abstract][Full Text] [Related]
8. Management of invasive aspergillosis in patients with COPD: rational use of voriconazole.
Ader F; Bienvenu AL; Rammaert B; Nseir S
Int J Chron Obstruct Pulmon Dis; 2009; 4():279-87. PubMed ID: 19684861
[TBL] [Abstract][Full Text] [Related]
9. Clinical Features and Prognosis of Invasive Pulmonary Aspergillosis in Korean Children with Hematologic/Oncologic Diseases.
Han SB; Kim SK; Bae EY; Lee JW; Yoon JS; Chung NG; Cho B; Jeong DC; Kang JH; Kim HK; Lee DG; Lee HS; Im SA
J Korean Med Sci; 2015 Aug; 30(8):1121-8. PubMed ID: 26240490
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy of advanced invasive pulmonary aspergillosis in transiently neutropenic rats using human pharmacokinetic equivalent doses of voriconazole and anidulafungin.
van de Sande WW; Mathot RA; ten Kate MT; van Vianen W; Tavakol M; Rijnders BJ; Bakker-Woudenberg IA
Antimicrob Agents Chemother; 2009 May; 53(5):2005-13. PubMed ID: 19237647
[TBL] [Abstract][Full Text] [Related]
11. Invasive pulmonary aspergillosis is associated with adverse clinical outcomes in critically ill patients receiving veno-venous extracorporeal membrane oxygenation.
Rodriguez-Goncer I; Thomas S; Foden P; Richardson MD; Ashworth A; Barker J; Geraghty CG; Muldoon EG; Felton TW
Eur J Clin Microbiol Infect Dis; 2018 Jul; 37(7):1251-1257. PubMed ID: 29623451
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics, radiologic findings, risk factors and outcomes of serum galactomannan-negative invasive pulmonary aspergillosis.
Jung J; Kim MY; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
J Microbiol Immunol Infect; 2018 Dec; 51(6):802-809. PubMed ID: 28712819
[TBL] [Abstract][Full Text] [Related]
13. Hospital costs and outcomes among intravenous antifungal therapies for patients with invasive aspergillosis in the United States.
Kim A; Nicolau DP; Kuti JL
Mycoses; 2011 Sep; 54(5):e301-12. PubMed ID: 20557463
[TBL] [Abstract][Full Text] [Related]
14. Clinical findings in 19 cases of invasive pulmonary aspergillosis with liver cirrhosis.
Chen J; Yang Q; Huang J; Li L
Multidiscip Respir Med; 2014 Jan; 9(1):1. PubMed ID: 24401649
[TBL] [Abstract][Full Text] [Related]
15. Characteristics and outcomes for pulmonary aspergillosis in critically ill patients without influenza: A 3-year retrospective study.
Chao CM; Lai CC; Chan KS; Yang CC; Chen CM; Ho CH; Ou HF; Yu WL
J Infect Public Health; 2023 Dec; 16(12):2001-2009. PubMed ID: 37890223
[TBL] [Abstract][Full Text] [Related]
16. Invasive pulmonary aspergillosis in non-neutropenic patients with and without underlying disease: a single-centre retrospective analysis of 52 subjects.
Dai Z; Zhao H; Cai S; Lv Y; Tong W
Respirology; 2013 Feb; 18(2):323-31. PubMed ID: 23051143
[TBL] [Abstract][Full Text] [Related]
17. Invasive pulmonary aspergillosis in non-neutropenic patients: analysis of a 14-month prospective clinical experience.
Russo A; Falcone M; Vena A; Venditti C; Mancini C; Morelli A; Venditti M
J Chemother; 2011 Oct; 23(5):290-4. PubMed ID: 22005062
[TBL] [Abstract][Full Text] [Related]
18. Short course of voriconazole therapy as a risk factor for relapse of invasive pulmonary aspergillosis.
Shin DH; Yoo SJ; Jun KI; Kim H; Kang CK; Song KH; Choe PG; Park WB; Bang JH; Kim ES; Park SW; Kim HB; Kim NJ; Oh MD
Sci Rep; 2020 Sep; 10(1):16078. PubMed ID: 32999399
[TBL] [Abstract][Full Text] [Related]
19. Impact of bronchoalveolar lavage galactomannan on the outcome of patients at risk for invasive pulmonary aspergillosis.
Danpornprasert P; Foongladda S; Tscheikuna J
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S86-93. PubMed ID: 20364562
[TBL] [Abstract][Full Text] [Related]
20. Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial.
Maertens JA; Rahav G; Lee DG; Ponce-de-León A; Ramírez Sánchez IC; Klimko N; Sonet A; Haider S; Diego Vélez J; Raad I; Koh LP; Karthaus M; Zhou J; Ben-Ami R; Motyl MR; Han S; Grandhi A; Waskin H;
Lancet; 2021 Feb; 397(10273):499-509. PubMed ID: 33549194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
